Aishworiya, R., Valica, T., Hagerman, R., & Restrepo, B. (2022). An update on psychopharmacological treatment of autism spectrum disorder. Neurotherapeutics, 19(1), 248–262. https://doi.org/10.1007/s13311-022-01183-1

Article  PubMed  PubMed Central  Google Scholar 

Alfageh, B. H., Man, K. K., Besag, F. M., Alhawassi, T. M., Wong, I. C., & Brauer, R. (2020). Psychotropic medication prescribing for neuropsychiatric comorbidities in individuals diagnosed with autism spectrum disorder (ASD) in the UK. Journal of Autism and Developmental Disorders, 50(2), 625–633. https://doi.org/10.1007/s10803-019-04291-8

Article  PubMed  Google Scholar 

Aman, M., Singh, N., Stewart, A., & Field, C. (1985). The aberrant behavior checklist: A behavior ratings scale for the assessment of treatment effects. American Journal of Mental Deficiency, 89, 485–491.

PubMed  Google Scholar 

APA. (2022). Diagnostic and Statistical Manual of Mental Disorders 5th Ed Text Revision. American Psychiatric Association. https://doi.org/10.1176/appi.books.9780890425787

Bernaerts, S., Boets, B., Bosmans, G., Steyaert, J., & Alaerts, K. (2020). Behavioral effects of multiple-dose oxytocin treatment in autism: A randomized, placebo-controlled trial with long-term follow-up. Molecular Autism, 11(1), 6. https://doi.org/10.1186/s13229-020-0313-1

Article  PubMed  PubMed Central  Google Scholar 

Bertelli, M. O. (2023). Psychotropic medication for problem behaviours in intellectual disability and autism spectrum disorder: The need for caution. British Journal of Psychiatry Advances, 1–3. https://doi.org/10.1192/bja.2023.22

Bitsika, V., Sharpley, C. F., & Bell, R. (2013). The buffering effect of resilience upon stress, anxiety and depression in parents of a child with an autism spectrum disorder. Journal of Developmental and Physical Disabilities, 25(5), 533–543. https://doi.org/10.1007/s10882-013-9333-5

Article  Google Scholar 

Bitsika, V., Heyne, D. A., & Sharpley, C. F. (2022). The inverse association between psychological resilience and emerging school refusal among bullied autistic youth. Research in Developmental Disabilities, 120, 104121. https://doi.org/10.1016/j.ridd.2021.104121

Article  PubMed  Google Scholar 

Bitsika, V., Sarmukadam, K., & Sharpley, C. F. (2023). Directional alpha frontoparietal connectivity and anxiety in autistic boys. Journal of Developmental and Physical Disabilities. https://doi.org/10.1007/s10882-023-09893-w

Article  Google Scholar 

Boksha, I. S., Prokhorova, T. A., Tereshkina, E. B., Savushkina, O. K., & Burbaeva, G. S. (2023). Differentiated approach to pharmacotherapy of autism spectrum disorders: Biochemical aspects. Biochemistry (Moscow), 88(3), 303–318.

Article  PubMed  Google Scholar 

Boyce, W. T., Levitt, P., Martinez, F. D., McEwen, B. S., & Shonkoff, J. P. (2021). Genes, environments, and time: The biology of adversity and resilience. Pediatrics, 147(2). https://doi.org/10.1542/peds.2020-1651

Cabral, J., Fernandes, F. F., & Shemesh, N. (2023). Intrinsic macroscale oscillatory modes driving long range functional connectivity in female rat brains detected by ultrafast fMRI. Nature Communications, 14(1), 375. https://doi.org/10.1038/s41467-023-36025-x

Article  PubMed  PubMed Central  Google Scholar 

Cai, Q., Feng, L., & Yap, K. Z. (2018). Systematic review and meta-analysis of reported adverse events of long-term intranasal oxytocin treatment for autism spectrum disorder. Psychiatry and Clinical Neurosciences, 72(3), 140–151. https://doi.org/10.1111/pcn.12627

Article  PubMed  Google Scholar 

Carthy, E., Ross, C., & Murphy, D. (2023). Psychotropic medication prescribing in people with autism spectrum disorders with and without psychiatric comorbidity. British Journal of Psychiatry Advances, 29(2), 131–140. https://doi.org/10.1192/bja.2021.32

Article  Google Scholar 

Chawner, S. J., Doherty, J. L., Anney, R. J., Antshel, K. M., Bearden, C. E., Bernier, R., Chung, W. K., Clements, C. C., Curran, S. R., & Cuturilo, G. (2021). A genetics-first approach to dissecting the heterogeneity of autism: Phenotypic comparison of autism risk copy number variants. American Journal of Psychiatry, 178(1), 77–86. https://doi.org/10.1176/appi.ajp.2020.20010015

Article  PubMed  Google Scholar 

Clark, M., & Adams, D. (2022, 2022/03/01). Resilience in autism and intellectual disability: A systematic review. Review Journal of Autism and Developmental Disorders, 9(1), 39–53. https://doi.org/10.1007/s40489-021-00239-w

Connor, K., & Davidson, J. (2003). Development of a new resilience scale: The Connor-Davidson resilience scale (CD-RISC). Depression and Anxiety, 18(2), 76–82. https://doi.org/10.1002/da.10113

Article  PubMed  Google Scholar 

Constantino, J., & Gruber, C. (2012). Social Responsiveness Scale second edition (SRS-2). Western Psychological Services.

Constantino, J. (2005). Social Responsiveness Scale-Adult Research Version. Western Psychological Services.

Daniels, N., Moerkerke, M., Steyaert, J., Bamps, A., Debbaut, E., Prinsen, J., Tang, T., Van der Donck, S., Boets, B., & Alaerts, K. (2023). Effects of multiple-dose intranasal oxytocin administration on social responsiveness in children with autism: A randomized, placebo-controlled trial. Molecular Autism, 14(1), 16. https://doi.org/10.1186/s13229-023-00546-5

Article  PubMed  PubMed Central  Google Scholar 

de Pablo, G. S., Pastor Jordá, C., Vaquerizo-Serrano, J., Moreno, C., Cabras, A., Arango, C., Hernández, P., Veenstra-VanderWeele, J., Simonoff, E., Fusar-Poli, P., Santosh, P., Cortese, S., & Parellada, M. (2023). Systematic review and meta-analysis: Efficacy of pharmacological interventions for irritability and emotional dysregulation in autism spectrum disorder and predictors of response. Journal of the American Academy of Child & Adolescent Psychiatry, 62(2), 151–168. https://doi.org/10.1016/j.jaac.2022.03.033

Article  Google Scholar 

Feder, A., Fred-Torres, S., Southwick, S. M., & Charney, D. S. (2019). The biology of human resilience: Opportunities for enhancing resilience across the life span. Biological Psychiatry, 86(6), 443–453. https://doi.org/10.1016/j.biopsych.2019.07.012

Article  PubMed  Google Scholar 

Feroe, A. G., Uppal, N., Gutierrez-Sacristan, A., Mousavi, S., Greenspun, P., Surati, R., Kohane, I. S., & Avillach, P. (2021). Medication use in the management of comorbidities among individuals with autism spectrum disorder from a large nationwide insurance database. JAMA Pediatrics, 175(9), 957–965. https://doi.org/10.1001/jamapediatrics.2021.1329

Article  PubMed  Google Scholar 

Ford, C. L., & Young, L. J. (2022). Refining oxytocin therapy for autism: Context is key. Nature Reviews Neurology, 18(2), 67–68. https://doi.org/10.1038/s41582-021-00602-9

Article  PubMed  PubMed Central  Google Scholar 

Frye, R. E. (2020). Mitochondrial dysfunction in autism spectrum disorder: Unique abnormalities and targeted treatments. Seminars in Pediatric Neurology, 35, 100829. https://doi.org/10.1016/j.spen.2020.100829

Article  PubMed  Google Scholar 

Frye, R. E., Cakir, J., Rose, S., Delhey, L., Bennuri, S. C., Tippett, M., Melnyk, S., James, S. J., Palmer, R. F., & Austin, C. (2021). Prenatal air pollution influences neurodevelopment and behavior in autism spectrum disorder by modulating mitochondrial physiology. Molecular Psychiatry, 26(5), 1561–1577. https://doi.org/10.1038/s41380-020-00885-2

Article  PubMed  Google Scholar 

Garcia-Gonzalez, S., Lugo-Marin, J., Setien-Ramos, I., Gisbert-Gustemps, L., Arteaga-Henriquez, G., Diez-Villoria, E., & Ramos-Quiroga, J. A. (2021). Transcranial direct current stimulation in autism spectrum disorder: A systematic review and meta-analysis. European Neuropsychopharmacology, 48, 89–109. https://doi.org/10.1016/j.euroneuro.2021.02.017

Article  PubMed  Google Scholar 

Genovese, A., & Ellerbeck, K. (2022). Autism spectrum disorder: A review of behavioral and psychiatric challenges across the lifespan. SN Comprehensive Clinical Medicine, 4(1), 217. https://doi.org/10.1007/s42399-022-01302-1

Article  Google Scholar 

Griff, J. R., Langlie, J., Bencie, N. B., Cromar, Z. J., Mittal, J., Memis, I., Wallace, S., Marcillo, A. E., Mittal, R., & Eshraghi, A. A. (2023). Recent advancements in noninvasive brain modulation for individuals with autism spectrum disorder. Neural Regeneration Research, 18(6), 1191–1195. https://doi.org/10.4103/1673-5374.360163

Article  PubMed  Google Scholar 

Guastella, A. J., Boulton, K. A., Whitehouse, A. J., Song, Y. J., Thapa, R., Gregory, S. G., Pokorski, I., Granich, J., DeMayo, M. M., & Ambarchi, Z. (2023). The effect of oxytocin nasal spray on social interaction in young children with autism: A randomized clinical trial. Molecular Psychiatry, 28(2), 834–842. https://doi.org/10.1038/s41380-022-01845-8

Article  PubMed  Google Scholar 

Hasan, R. A., Ali, S. S. A., Tang, T. B., & Yusoff, M. S. B. (2022). Finding the EEG footprint of stress resilience. International Conference on Artificial Intelligence for Smart Community: AISC 2020, 17–18 December, Universiti Teknologi Petronas, Malaysia.

Henneberry, E., Lamy, M., Dominick, K. C., & Erickson, C. A. (2021). Decades of progress in the psychopharmacology of autism spectrum disorder. Journal of Autism and Developmental Disorders, 51, 4370–4394. https://doi.org/10.1007/s10803-021-05237-9

Article  PubMed  Google Scholar 

Henry, R., Deckert, M., Guruviah, V., & Schmidt, B. (2016). Review of neuromodulation techniques and technological limitations. IETE Technical Review, 33(4), 368–377.

Article  Google Scholar 

Herrman, H., Stewart, D. E., Diaz-Granados, N., Berger, E. L., Jackson, B., & Yuen, T. (2011). What is resilience? The Canadian Journal of Psychiatry, 56(5), 258–265. https://doi.org/10.1177/0706743711056005

Article  PubMed  Google Scholar 

Huang, Y., Huang, X., Ebstein, R. P., & Yu, R. (2021). Intranasal oxytocin in the treatment of autism spectrum disorders: a multilevel meta-analysis. Neuroscience & Biobehavioral Reviews, 122, 18–27. https://doi.org/10.1016/j.neubiorev.2020.12.028

Article  Google Scholar 

Insel, T. (2013). Transforming diagnosis. National Institute of Mental Health. Retrieved May 27 from https://www.nimh.nih.gov/about/director/2013/transforming-diagnosis-shtml

John, S., & Jaeggi, A. V. (2021). Oxytocin levels tend to be lower in autistic children: A meta-analysis of 31 studies. Autism, 25(8), 2152–2161. https://doi.org/10.1177/13623613211034

Article  PubMed  Google Scholar 

Khaleghi, A., Zarafshan, H., Vand, S. R., & Mohammadi, M. R. (2020). Effects of non-invasive neurostimulation on autism spectrum disorder: A systematic review. Clinical Psychopharmacology and Neuroscience, 18(4), 527. https://doi.org/10.9758/cpn.2020.18.4.527

Article  PubMed  PubMed Central  Google Scholar 

Lewis, P. M., Thomson, R. H., Rosenfeld, J. V., & Fitzgerald, P. B. (2016). Brain neuromodulation techniques: A review. The Neuroscientist, 22(4), 406–421. https://doi.org/10.1177/1073858416646707

Article  PubMed  Google Scholar 

Lim, R., Moffat, A. K., Young, R., & Kalisch Ellett, L. M. (2021). Use of medicines in adults with autism spectrum disorder in Australia. Journal of Pharmacy Practice and Research, 51(5), 410–414. https://doi.org/10.1002/jppr.1745

Article  Google Scholar 

Long, Y., Chen, C., Deng, M., Huang, X., Tan, W., Zhang, L., Fan, Z., & Liu, Z. (2019). Psychological resilience negatively correlates with resting-state brain network flexibility in young healthy adults: A dynamic functional magnetic resonance imaging study. Annals of Translational Medicine, 7(24), 809. https://doi.org/10.21037/atm.2019.12.45

Article  PubMed  PubMed Central  Google Scholar 

Luthar, S., & Cicchetti, D. (2000). The construct of resilience: Implications for interventions and social policies. Development and Psychopathology, 12(4), 857–885. https://doi.org/10.1017/s0954579400004156